Xtx Topco LTD Bio Xcel Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $710 Million
- Q1 2024
A detailed history of Xtx Topco LTD transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 31,212 shares of BTAI stock, worth $34,333. This represents 0.01% of its overall portfolio holdings.
Number of Shares
31,212Holding current value
$34,333% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding BTAI
# of Institutions
77Shares Held
6.6MCall Options Held
85KPut Options Held
221K-
Black Rock Inc. New York, NY1.33MShares$1.46 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$1.21 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN579KShares$637,0800.0% of portfolio
-
State Street Corp Boston, MA465KShares$511,3980.0% of portfolio
-
Geode Capital Management, LLC Boston, MA458KShares$503,7120.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $30.8M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...